NFSG
EBS icon

Newbridge Financial Services Group’s Emergent Biosolutions EBS Stock Holding History

Newbridge Financial Services Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-500
Closed -$1.7K – 1212
2023
Q3 		$1.7K Sell
500
-2,550
-84% -$14.1K ﹤0.01% 1099
2023
Q2 		$22.4K Sell
3,050
-3,600
-54% -$33.4K 0.01% 663
2023
Q1 		$68.9K Buy
+6,650
New +$80.4K 0.04% 392

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Newbridge Financial Services Group's EBS Position: Q4 2023 in Review

Newbridge Financial Services Group sold out of Emergent Biosolutions (EBS) in Q4 2023, closing a stake of 500 shares — an estimated $1.7K sold.

Newbridge Financial Services Group first reported a position in EBS in Q1 2023 and held it in 3 quarters. The position peaked at $68.9K in Q1 2023. 134 funds tracked by Wall St. Rank hold EBS as of Q4 2023.

  • Newbridge Financial Services Group reported no remaining Emergent Biosolutions position as of Q4 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 500 Emergent Biosolutions shares in Q4 2023, an estimated $1.7K.
  • Newbridge Financial Services Group first reported a position in Emergent Biosolutions in Q1 2023 and held it in 3 quarters.
  • Newbridge Financial Services Group's Emergent Biosolutions position peaked at $68.9K in Q1 2023.
  • 134 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q4 2023.

Based on Newbridge Financial Services Group's 13F filing for Q4 2023, filed 28 Mar 2024.